Author:
Zhang Qingyu,Liu Jie,Liu Bin,Xia Juan,Chen Nianping,Chen Xiaofeng,Cao Yi,Zhang Chen,Lu CaiJie,Li Mingyi,Zhu Runzhi
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Feng, M. et al. Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma. P Natl Acad Sci USA 110, E1083–E1091(2013).
2. Wilson, T. R. et al. Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature 487, 505–509 (2012).
3. Meyskens, F. L. & Gerner, E. W. Development of Difluoromethylornithine (DFMO) as a Chemoprevention Agent. Clin Cancer Res 5, 945–951 (1999).
4. Suzuki, R. et al. Effective anti-tumor activity of oxaliplatin encapsulated in transferrin–PEG-liposome. Int J Pharm 346, 143–150 (2008).
5. Florea, A.-M. & Büsselberg, D. Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancers 3, 1351–1371 (2011).
Cited by
66 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献